247 The primary action often occurs through indirect mechanisms, such as insulin and somatostatin
Applied Clinical Genetics, 16 , 3139
If semaglutide made up 80% of GLP-1 volume (before Zepbound), that implies compounded share closer to 32% (source) Now, look at Hims: They launched compounded semaglutide in Q2 2024 and reported $225M in GLP-1 revenue through year-end (source)
Potential Relevance for Individuals With PCOS In women with PCOS and overweight or obesity, standard-dose GLP-1 receptor agonists have been studied for their potential effects on weight, insulin resistance, and hormonal markers, including androgen levels and menstrual regularity
External resources For researchers serious about protecting their semaglutide investment and optimizing every aspect of their protocol, SeekPeptides offers the most comprehensive resource available